Kezar Life Sciences, Inc. — Director's Dealing 2023

Jan 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2023-01-05

Reporting Person: Morningside Venture Investments Ltd (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-05	Common Stock	S	12162	$6.97	Disposed	5889078	Direct
2023-01-06	Common Stock	S	3000	$6.89	Disposed	5886078	Direct

Footnotes

F1: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.89 to $7.17, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.68 to $7.12, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.